Based on the accumulated evidence presented in this study, RA with sSS and/or positivity for anti-Ro/SS-A antibodies could be considered a phenotype different from isolated RA, requiring different therapeutic strategies. The gene discussed is RO60; the disease is rheumatoid arthritis.